Načítá se...
Sequential and combination treatments with novel agents in chronic lymphocytic leukemia
Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia for a long time. However, over the last few years, novel agents have produced unprecedented outcomes in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia. With the advent of these targe...
Uloženo v:
| Vydáno v: | Haematologica |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Ferrata Storti Foundation
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821614/ https://ncbi.nlm.nih.gov/pubmed/31585959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.208603 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|